Drug manufacturers warn of lack of production, the Ministry does not agree

The Department of Health rejects price criticism and claims that manufacturers are chaotic because they want to return to the old-fashioned sales.

In July, the list of reimbursable drug prices was renewed each quarter. Darwin Sinkevicius, chairman of the board of directors of the Association of Pharmaceutical Manufacturers, said that under the new procedure, the number of preparations falls in the price list, which makes them insufficient for patients [19659004]. that the current valid requirements for the preservation of the price of drugs reimbursed for a single drug are too stringent, "said representatives of pharmaceutical companies after the meeting at the Ministry.

According to him, there are currently 4 to 5 drugs against Urinary Incontinence, Prostate Heart Disease, Hypertension

According to Mr. Sinkevicius, twenty drugs could fail in the next two weeks and alternatives to all these drugs would not be compensated.

"The Solution would be to have a larger number of manufacturers in reimbursed drugs that even Deputy Minister of Health Kristina Garuolienė BNS said that drug manufacturers are promoting routine problems in order to discredit a new order in the price list of reimbursable medicines.

realize that this mechanism of drug supply is alive. This has always been, and no one has written about it, but since the new diet came into effect and that it does not like manufacturers to reduce the price of drugs, they are looking for to show that this order is bad and that it must necessarily be canceled.

According to her, whenever she sees that there may be a shortage of certain countervailing drugs on the market, the price list is adjusted

Ms. Garuolinė argued that in this case, patients will not receive any medication

. routine He is alive – some drugs fall, others engage, but patients receive treatment as needed. Drug manufacturers also criticize the ministry that the price of reimbursement drugs is approved each time before it comes into effect two weeks and is not enough to properly prepare for the supply of drugs.

Ms. Garuolienė argued that this criticism was unreasonable, because the manufacturer always discovers if its drug will be evaluated.

"Manufacturers submit an application and submit an application must physically have the drug that they will provide," she said. The Patient Fund (VLK) announced that a new reimbursement policy, which came into effect on July 1, totaled 2,050 drugs. According to the VLK, the basic price of drugs decreased by 552 and the price of one of the products has not increased.

SNB news agencies retrieve information in the media and on websites without the written letter of BNS UAB "consent is not allowed.

Write a comment